随机对照试验研究熊去氧胆酸治疗原发性胆汁性肝硬化患者的疗效及安全性*

doi:10.3969/j.issn.1672-5069.2017.01.030

Abstract

Guo Rui, Tan Jin.. A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 109-110.

[1] Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med,2005, 353（12）:1261-1273.
[2] 施健,刘苏,陈伟忠,等. 中等剂量熊去氧胆酸治疗原发性胆汁性肝硬化的系统评价. 中华消化杂志,2005,25（6）:355-358.
[3] 孔祥璐,郭晓霞. 中药联合熊去氧胆酸胶囊治疗原发性胆汁性肝硬化疗效系统评价. 实用肝脏病杂志,2015,18（4）:379-382.
[4] 端木潜,何峰,王智胜,等. 熊去氧胆酸治疗原发性胆汁性肝硬化1年总结报告. 实用肝脏病杂志,2009,12（1）:50-52.
[5] 李红艺,杨梦晗,孟霄,等. 熊去氧胆酸治疗原发性胆汁性肝硬化患者早期应答预测1年疗效.实用肝脏病杂志,2013,16（2）:108-110.
[6] 杨梦晗,尤红. 熊去氧胆酸治疗原发性胆汁性肝硬化生化应答标准及治疗研究进展. 实用肝脏病杂志,2013,16（2）:169-171.
[7] 谢函君,叶志伟. 熊去氧胆酸联合中药治疗原发性胆汁性肝硬化疗效观察. 中西医结合肝病杂志,2016,26（1）:52-54.
[8] 江龙中,陈亮,陈弈. 熊去氧胆酸治疗不同临床分期原发性胆汁性肝硬化患者2年临床疗效观察.实用肝脏病杂志,2014,17（4）:422-424.
[9] 李斌,黄志碧,方益敏,等. 熊去氧胆酸治疗原发性胆汁性肝硬化的系统评价. 广西医学,2009,31（2）:157-159.
[10] 毛莉萍,徐建中. 熊去氧胆酸胶囊联合甘草酸二铵注射液治疗原发性胆汁性肝硬化临床疗效评价.实用临床医药杂志,2013,17（3）:73-74,87.
[11] Lindor KD,Gershwin ME,Poupon R,et al. AASLD Practice Guidilines:Primary biliary cirrhosis. Hepatology,2009,50（1）:291-308.
[12] European Association for the Study of the Liver. EASL Clinical Practice Guidelines:management of cholestatic liver disease. J Hepatol,2009,51（2） :237-267.
[13] 黎钟燕. 熊去氧胆酸治疗原发性胆汁性肝硬化临床观察.中国现代医生,2010,48（33）:65-66.
[14] 仲人前,钱睁. 原发性胆汁性肝硬化发病机制研究及展望. 中国实验诊断学,2008,12（5）:691-694.
[15] 吴颖,姚定康,朱樑,等. 熊去氧胆酸联合扶正化瘀胶囊治疗原发性胆汁性肝硬化临床观察.中国中西医结合杂志,2012,32（11）:1477-1182.
[16] 樊宏伟,范亚硕,丁小琳. 熊去氧胆酸治疗原发性胆汁性肝硬化的疗效分析. 实用肝脏病杂志,2006,9（4）:245-246.
[17] 朱玉侠,郭玲,高正军,等. 熊去氧胆酸治疗原发性胆汁性肝硬化疗效观察. 陕西医学杂志,2014,43（10）:1398-1400.
[18] 赵占学,李帅,景鸿恩. 熊去氧胆酸治疗原发性胆汁性肝硬化临床观察. 生物技术世界,2016,11（4）:107.

A randomized controlled trial of ursodeoxycholic acid in treating patients with primary biliary cirrhosis

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Xing Xin, Wei Zhongcao, Zhou mimi, et al.. Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis [J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
[2]	Duan Chuyao, Chen Qingshan, Wang Liming, et al.. Clinical efficacy of ursodeoxycholic acid in treatment of patients with intrahepatic cholestasis of pregnancy [J]. Journal of Practical Hepatology, 2019, 22(6): 864-867.
[3]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[4]	Chen Meimei, Duan Xiaoyan, Cao Haixia, et al.. Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets [J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
[5]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[6]	Bian Xinqu, Chen Jie, Liu Yanmin, et al. Serum thyroid hormone level changes in patients with primary biliary cholangitis receiving ursodeoxycholic acid therapy [J]. Journal of Practical Hepatology, 2019, 22(5): 716-719.
[7]	Zhang Zhicheng, Yuan Guangqi, Mo Chanjun. Impact of blood supply on efficacy of hepatic artery embolization in treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2019, 22(5): 736-739.
[8]	Lu Lungen. Cholestatic liver diseases：What we know and how to deal with [J]. Journal of Practical Hepatology, 2019, 22(5): 754-757.
[9]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[10]	Yuan Chunhui, Li Chunyu, Li Hongli. Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
[11]	Ma Xiaosu, Pei Renming Zhang Tingting. Comparison of magnetic resonance cholangiopancreatography with color Doppler ultrasound in diagnosis of patients with common bile duct stones [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 433-436.
[12]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.
[13]	Yan Huanjie, Zhang Shuqin, Zhao Wenjing.. Therapeutic efficacy of autologous bone marrow stem cell transplantation for treatment of patients with hepatitis B-induced acute-on-chronic liver failure [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 81-84.
[14]	Wang Chan, Qin Wei, Dai Yong, et al.. Clinical efficacy of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 97-100.
[15]	Ma Lyuxiang, Zhang Xuesong.. Efficacy and prognosis of ultrasound-guided percutaneous radiofrequency ablation in treatment of patients with small hepatocellular carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 125-128.